1. Selzer A. Changing aspects of the natural history of valvular aortic stenosis.N Engl J Med 1987; 317:91- 8.
2. Dare AJ, Veinot JP, Edwards WD, Tazelaar HD, Schaff HV. New observations on the etiology of aortic valve disease: a surgical pathologic study of 236 cases from 1990. Hum Pathol 1993; 24:13308.
3. Stephan PJ, Henry AC III, Hebeler RF Jr, Whiddon L, Roberts WC. Comparison of age, gender, number of aortic valve cusps, concomitant coronary artery bypass grafting, and magnitude of left ventricular-systemic arterial peak systolic gradient in adults having aortic valve replacementfor isolated aortic valve stenosis. Am J Cardiol 1997; 79:166 -72.
4. Roberts WC, Ko JM. Frequency by decades of unicuspid, bicuspid, and tricuspid aortic valves in adults having isolated aortic valve replacement for aortic stenosis, with or without associated aortic regurgitation. Circulation 2005; 111:920 -5.
5. Olsson M, Dalsgaard CJ, Haegerstrand A, Rosenqvist M, Ryden L, Nilsson J. Accumulation of T lymphocytes and expression of interleukin-2 receptors in nonrheumatic stenotic aortic valves. J Am Coll Cardiol 1994; 23:1162-70.
6. Otto CM, Kuusisto J, Reichenbach DD, Gown AM, O’Brien KD. Characterization of the early lesion of “degenerative” valvular aortic stenosis: histological and immunohistochemical studies. Circulation 1994; 90:844 -53.
7. O’Brien KD, Reichenbach DD, Marcovina SM, Kuusisto J, Alpers CE, Otto CM. Apolipoproteins B, (a), and E accumulate in the morphologically early lesion of “degenerative” valvular aortic stenosis. Arterioscler Thromb Vasc Biol 1996; 16:523-32.
8. Mohler ER III, Chawla MK, Chang AW, et al. Identification and characterization of calcifying valve cells from human and canine aortic valves. J Heart Valve Dis 1999; 8:254-60.
9. Olsson M, Thyberg J, Nilsson J. Presence of oxidized low-density lipoprotein in nonrheumatic stenotic aortic valves. Arterioscler Thromb Vasc Biol 1999; 19:1218 -22.
10. Dunning J, Versteegh M, Fabbri A, Pavie A, Kolh P, Lockowandt U, Nashef SA; EACTS Audit and Guidelines Committee. Guideline on antiplatelet and anticoagulation management in cardiac surgery. Eur J Cardiothorac Surg 2008;34:73-92.
11. Mohler ER III, Gannon F, Reynolds C, Zimmerman R, Keane MG, Kaplan FS. Bone formation and inflammation in cardiac valves.Circulation 2001; 103:1522- 8.
12. Rajamannan NM, Sangiorgi G, Springett M, et al. Experimental hypercholesterolemia induces apoptosis in the aortic valve. J Heart Valve Dis 2001; 10:371- 4.
13. O’Brien KD, Shavelle DM, Caulfield MT, et al. Association of angiotensinconverting enzyme with low-density lipoprotein in aortic valvular lesions and in human plasma. Circulation 2002; 106:2224-30.
14. Wallby L, Janerot-Sjoberg B, Steffensen T, Broqvist M. T lymphocyte infiltration in nonrheumatic aortic stenosis: a comparative descriptive study between tricuspid and bicuspid aortic valves. Heart 2002; 88:348 -51.
15. Rajamannan NM, Subramaniam M, Rickard D, et al. Human aortic valve calcification is associated with an osteoblast phenotype. Circulation 2003; 107:2181-4.
16. Sasayama S, Ross J Jr, Franklin D, Bloor CM, Bishop S, Dilley RB. Adaptations of the left ventricle to chronic pressure overload. Circ Res 1976; 38:172- 8.
17. Gaasch WH. Left ventricular radius to wall thickness ratio. Am J Cardiol 1979; 43:1189 -94.
18. Spann JF, Bove AA, Natarajan G, Kreulen T. Ventricular performance, pump function and compensatory mechanisms in patients with aortic stenosis. Circulation 1980; 62:576-82.
19. Krayenbuehl HP, Hess OM, Ritter M, Monrad ES, Hoppeler H. Left ventricular systolic function in aortic stenosis. Eur Heart J 1988; 9 Suppl E: 19-23.
20. Ross J Jr. Afterload mismatch and preload reserve: a conceptual framework for the analysis of ventricular function. Prog Cardiovasc Dis 1976; 18:255- 64.
21. Gunther S, Grossman W. Determinants of ventricular function in pressure-overload hypertrophy in man. Circulation 1979; 59:679-88.
22 Huber D, Grimm J, Koch R, Krayenbuehl HP. Determinants of ejection performance in aortic stenosis.Circulation 1981; 64:126-34.
23 Carabello BA, Green LH, Grossman W, Cohn LH, Koster JK, Collins JJ Jr. Hemodynamic determinants of prognosis of aortic valve replacement in critical aortic stenosis and advanced congestive heart failure. Circulation 1980; 62:42- 8.
24. Gaasch WH, Levine HJ, Quinones MA, Alexander JK. Left ventricular compliance: mechanisms and clinical implications. Am J Cardiol 1976; 38:645-53.
25. Hess OM, Ritter M, Schneider J, Grimm J, Turina M, Krayenbuehl HP. Diastolic stiffness and myocardial structure in aortic valve disease before and after valve replacement. Circulation 1984; 69:55-65.
26. Murakami T, Hess OM, Gage JE, Grimm J, Krayenbuehl HP.Diastolic filling dynamics in patients with aortic stenosis. Circulation1986; 73:1162-74.
27. Stott DK, Marpole DG, Bristow JD, Kloster FE, Griswold HE.The role of left atrial transport in aortic and mitral stenosis.Circulation 1970;41:1031- 41.
28. Bache RJ, Vrobel TR, Ring WS, Emery RW, Andersen RW.Regional myocardial blood flow during exercise in dogs with chronicleft ventricular hypertrophy. Circ Res 1981; 48:76-87.
29. Marcus ML, Doty DB, Hiratzka LF, Wright CB, Eastham CL.Decreased coronary reserve: a mechanism for angina pectoris inpatients with aortic stenosis and normal coronary arteries. N EnglJ Med 1982; 307:1362- 6.
30. Carabello BA. Clinical practice: aortic stenosis. N Engl J Med2002; 346:677- 82.
32. Otto CM, Burwash IG, Legget ME, et al. Prospective study of asymptomatic valvular aortic stenosis: clinical, echocardiographic, and exercise predictors of outcome. Circulation 1997; 95:226270.
33. Cheitlin MD, Gertz EW, Brundage BH, Carlson CJ, Quash JA,Bode RS Jr. Rate of progression of severity of valvular aortic stenosisin the adult. Am Heart J 1979; 98:689 -700.